Pancreatic cancer: between bench and bedside

Curr Drug Targets. 2012 Jun;13(6):729-30. doi: 10.2174/138945012800564130.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Humans
  • Molecular Biology / methods
  • Molecular Targeted Therapy*
  • Pancreatic Neoplasms / diagnosis
  • Pancreatic Neoplasms / pathology
  • Pancreatic Neoplasms / therapy*
  • Prognosis
  • Survival Rate